Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 134

1.

Blood markers of cardiac stress after generalized convulsive seizures.

Nass RD, Motloch LJ, Paar V, Lichtenauer M, Baumann J, Zur B, Hoppe UC, Holdenrieder S, Elger CE, Surges R.

Epilepsia. 2019 Jan 15. doi: 10.1111/epi.14637. [Epub ahead of print]

PMID:
30645779
2.

Differential Prognostic Value of Galectin-3 According to Carbohydrate Antigen 125 Levels in Transcatheter Aortic Valve Implantation.

Rheude T, Pellegrini C, Núñez J, Joner M, Trenkwalder T, Mayr NP, Holdenrieder S, Bodi V, Koenig W, Kasel AM, Schunkert H, Kastrati A, Hengstenberg C, Husser O.

Rev Esp Cardiol (Engl Ed). 2018 Oct 25. pii: S1885-5857(18)30390-6. doi: 10.1016/j.rec.2018.09.006. [Epub ahead of print] English, Spanish.

PMID:
30482731
3.

Bi-allelic Mutations in LSS, Encoding Lanosterol Synthase, Cause Autosomal-Recessive Hypotrichosis Simplex.

Romano MT, Tafazzoli A, Mattern M, Sivalingam S, Wolf S, Rupp A, Thiele H, Altmüller J, Nürnberg P, Ellwanger J, Gambon R, Baumer A, Kohlschmidt N, Metze D, Holdenrieder S, Paus R, Lütjohann D, Frank J, Geyer M, Bertolini M, Kokordelis P, Betz RC.

Am J Hum Genet. 2018 Nov 1;103(5):777-785. doi: 10.1016/j.ajhg.2018.09.011. Epub 2018 Oct 25.

PMID:
30401459
4.

Sequence analysis of cell-free DNA derived from cultured human bone osteosarcoma (143B) cells.

Bronkhorst AJ, Wentzel JF, Ungerer V, Peters DL, Aucamp J, de Villiers EP, Holdenrieder S, Pretorius PJ.

Tumour Biol. 2018 Sep;40(9):1010428318801190. doi: 10.1177/1010428318801190.

PMID:
30261820
5.

Diagnostic and prognostic value of circulating lncRNA H19 in gastric cancer.

Yörüker EE, Keskin M, Kulle CB, Holdenrieder S, Gezer U.

Biomed Rep. 2018 Aug;9(2):181-186. doi: 10.3892/br.2018.1116. Epub 2018 Jun 22.

6.

Circulating microRNAs are associated with Pulmonary Hypertension and Development of Chronic Lung Disease in Congenital Diaphragmatic Hernia.

Herrera-Rivero M, Zhang R, Heilmann-Heimbach S, Mueller A, Bagci S, Dresbach T, Schröder L, Holdenrieder S, Reutter HM, Kipfmueller F.

Sci Rep. 2018 Jul 16;8(1):10735. doi: 10.1038/s41598-018-29153-8.

7.

Improved sensitivity for detection of breast cancer by combination of miR-34a and tumor markers CA 15-3 or CEA.

Zaleski M, Kobilay M, Schroeder L, Debald M, Semaan A, Hettwer K, Uhlig S, Kuhn W, Hartmann G, Holdenrieder S.

Oncotarget. 2018 Apr 27;9(32):22523-22536. doi: 10.18632/oncotarget.25077. eCollection 2018 Apr 27.

8.

Technical and clinical performance of a new assay to detect squamous cell carcinoma antigen levels for the differential diagnosis of cervical, lung, and head and neck cancer.

Holdenrieder S, Molina R, Qiu L, Zhi X, Rutz S, Engel C, Kasper-Sauer P, Dayyani F, Korse CM.

Tumour Biol. 2018 Apr;40(4):1010428318772202. doi: 10.1177/1010428318772202.

PMID:
29701125
9.

Comparison of Carbohydrate Antigen 125 and N-Terminal Pro-Brain Natriuretic Peptide for Risk Prediction After Transcatheter Aortic Valve Implantation.

Rheude T, Pellegrini C, Schmid H, Trenkwalder T, Mayr NP, Joner M, Kasel AM, Holdenrieder S, Nunez J, Sanchis J, Bodi V, Schunkert H, Kastrati A, Hengstenberg C, Husser O.

Am J Cardiol. 2018 Feb 15;121(4):461-468. doi: 10.1016/j.amjcard.2017.11.020. Epub 2017 Nov 27.

PMID:
29306485
10.

Determinants of elevated carbohydrate antigen 125 in patients with severe symptomatic aortic valve stenosis referred for transcatheter aortic valve implantation.

Rheude T, Pellegrini C, Reinhard W, Trenkwalder T, Koenig W, Mayr NP, Joner M, Núñez J, Holdenrieder S, Schunkert H, Kastrati A, Hengstenberg C, Husser O.

Biomarkers. 2018 May;23(3):299-304. doi: 10.1080/1354750X.2018.1423706. Epub 2018 Jan 15.

PMID:
29297708
11.

Evaluation of cellulose pads as a method to detect cytomegalovirus DNA in neonatal urine.

Kipfmueller F, Jungbluth K, Eis-Hübinger AM, Reber U, Holdenrieder S, Gembruch U, Bartmann P, Mueller A.

Ann Clin Biochem. 2018 Sep;55(5):553-560. doi: 10.1177/0004563217750183. Epub 2018 Jan 30.

PMID:
29216741
12.

Circular RNA maps paving the road to biomarker development?

Görlach A, Holdenrieder S.

J Mol Med (Berl). 2017 Nov;95(11):1137-1141. doi: 10.1007/s00109-017-1603-8. No abstract available.

PMID:
29067477
13.

Clinical performance of LOCI™-based tumor marker assays for tumor markers CA 15-3, CA 125, CEA, CA 19-9 and AFP in gynecological cancers.

Dolscheid-Pommerich RC, Keyver-Paik M, Hecking T, Kuhn W, Hartmann G, Stoffel-Wagner B, Holdenrieder S.

Tumour Biol. 2017 Oct;39(10):1010428317730246. doi: 10.1177/1010428317730246.

PMID:
29034816
14.

[Multicenter Evaluation of A New Progastrin-releasing Peptide (ProGRP) Immunoassay across Europe and China].

Korse CM, Holdenrieder S, Zhi X, Zahng X, Qiu L, Geistanger A, Lisy MR, Wehnl B, Broek DVD, Escudero JM, Standop J, Hu M, Molina R.

Zhongguo Fei Ai Za Zhi. 2017 Aug 20;20(8):568-577. doi: 10.3779/j.issn.1009-3419.2017.08.12. Chinese.

15.

Soluble ST2 for Risk Stratification and the Prediction of Mortality in Patients Undergoing Transcatheter Aortic Valve Implantation.

Stundl A, Lünstedt NS, Courtz F, Freitag-Wolf S, Frey N, Holdenrieder S, Zur B, Grube E, Nickenig G, Werner N, Frank D, Sinning JM.

Am J Cardiol. 2017 Sep 15;120(6):986-993. doi: 10.1016/j.amjcard.2017.06.033. Epub 2017 Jun 29.

PMID:
28739033
16.

Serum levels of soluble programmed death protein 1 (sPD-1) and soluble programmed death ligand 1 (sPD-L1) in advanced pancreatic cancer.

Kruger S, Legenstein ML, Rösgen V, Haas M, Modest DP, Westphalen CB, Ormanns S, Kirchner T, Heinemann V, Holdenrieder S, Boeck S.

Oncoimmunology. 2017 Mar 31;6(5):e1310358. doi: 10.1080/2162402X.2017.1310358. eCollection 2017.

17.

Diagnostic relevance of a novel multiplex immunoassay panel in breast cancer.

Hermann N, Dressen K, Schroeder L, Debald M, Schildberg FA, Walgenbach-Bruenagel G, Hettwer K, Uhlig S, Kuhn W, Hartmann G, Holdenrieder S.

Tumour Biol. 2017 Jun;39(6):1010428317711381. doi: 10.1177/1010428317711381.

PMID:
28618926
18.

Prognostic value of alkaline phosphatase in patients with acute coronary syndromes.

Ndrepepa G, Holdenrieder S, Xhepa E, Cassese S, Fusaro M, Laugwitz KL, Schunkert H, Kastrati A.

Clin Biochem. 2017 Oct;50(15):828-834. doi: 10.1016/j.clinbiochem.2017.05.020. Epub 2017 Jun 1.

PMID:
28579339
19.

The Impact of SMAD4 Loss on Outcome in Patients with Advanced Pancreatic Cancer Treated with Systemic Chemotherapy.

Ormanns S, Haas M, Remold A, Kruger S, Holdenrieder S, Kirchner T, Heinemann V, Boeck S.

Int J Mol Sci. 2017 May 19;18(5). pii: E1094. doi: 10.3390/ijms18051094.

20.

Free-Circulating Methylated DNA in Blood for Diagnosis, Staging, Prognosis, and Monitoring of Head and Neck Squamous Cell Carcinoma Patients: An Observational Prospective Cohort Study.

Schröck A, Leisse A, de Vos L, Gevensleben H, Dröge F, Franzen A, Wachendörfer M, Schröck F, Ellinger J, Teschke M, Wilhelm-Buchstab T, Landsberg J, Holdenrieder S, Hartmann G, Field JK, Bootz F, Kristiansen G, Dietrich D.

Clin Chem. 2017 Jul;63(7):1288-1296. doi: 10.1373/clinchem.2016.270207. Epub 2017 May 17.

Supplemental Content

Loading ...
Support Center